Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA/BIO Get "Innovation" And "Modern Medicare" Into GOP Rhetoric

Executive Summary

Sen. Frist (R-Tenn.) spotlighted "innovation" as the updated GOP theme for protecting the drug industry against anticipated attacks from the Gore campaign during an Aug. 3 speech to the Republican National Convention in Philadelphia.

You may also be interested in...



Gore Links Pharmaceutical Industry To GOP, Bush In Acceptance Speech

Vice President Al Gore highlighted his willingness to fight pharmaceutical industry pressure as a point of difference between himself and Texas Gov. George W. Bush during his acceptance speech at the Democratic national convention Aug. 17 in Los Angeles.

Gore Links Pharmaceutical Industry To GOP, Bush In Acceptance Speech

Vice President Al Gore highlighted his willingness to fight pharmaceutical industry pressure as a point of difference between himself and Texas Gov. George W. Bush during his acceptance speech at the Democratic national convention Aug. 17 in Los Angeles.

Clinton Medicare Rx Plan Would Give Program Pricing "Clout" - Families USA

Expanding Medicare to include prescription drug coverage would give the program a level of price bargaining power similar to that held by Canadian provinces, Families USA Executive Director Ron Pollack suggested during a July 31 press briefing to unveil a new drug cost study.

Related Content

UsernamePublicRestriction

Register

PS036478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel